{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:06:55Z","timestamp":1791090415299,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["2R01ES10751"],"award-info":[{"award-number":["2R01ES10751"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.parkreldis.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T07:41:55Z","timestamp":1363419715000},"page":"595-599","source":"Crossref","is-referenced-by-count":29,"title":["Genetic susceptibility loci, environmental exposures, and Parkinson's disease: A case\u2013control study of gene\u2013environment interactions"],"prefix":"10.1016","volume":"19","author":[{"given":"Sun Ju","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.","family":"Armasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Lesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Eric","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrius M.","family":"Maraganore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2013.02.008_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ana.20668","article-title":"Phenotypic heterogeneity within a new family with the MAPT p301s mutation","volume":"58","author":"Yasuda","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"377","author":"Nalls","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib5","doi-asserted-by":"crossref","first-page":"e1002141","DOI":"10.1371\/journal.pgen.1002141","article-title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease","volume":"7","author":"Do","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib6","doi-asserted-by":"crossref","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2990.2007.00888.x","article-title":"LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease","volume":"34","author":"Alegre-Abarrategui","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","article-title":"Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case\u2013control study","volume":"55","author":"Benedetti","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/mds.870070407","article-title":"Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case\u2013control study","volume":"7","author":"Jimenez-Jimenez","year":"1992","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.21717","article-title":"Professional exposure to pesticides and Parkinson disease","volume":"66","author":"Elbaz","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00441-004-0937-z","article-title":"Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration","volume":"318","author":"Uversky","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2353\/ajpath.2007.060359","article-title":"Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model","volume":"170","author":"Norris","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/01.wnl.0000304049.31377.f2","article-title":"Alpha-synuclein, pesticides, and Parkinson disease: a case\u2013control study","volume":"70","author":"Brighina","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000315157","article-title":"alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease","volume":"35","author":"Gatto","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.23376","article-title":"Common variants in PARK loci and related genes and Parkinson's disease","volume":"26","author":"Chung","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.parkreldis.2011.07.001","article-title":"Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?","volume":"17","author":"Biernacka","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oxfordjournals.aje.a113955","article-title":"Random digit dialing in selecting a population-based control group","volume":"120","author":"Hartge","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib21","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mds.21009","article-title":"Chemical exposures and Parkinson's disease: a population-based case\u2013control study","volume":"21","author":"Frigerio","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib22","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.22247","article-title":"Coffee, caffeine-related genes, and Parkinson's disease: a case\u2013control study","volume":"23","author":"Facheris","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.parkreldis.2008.11.011","article-title":"Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case\u2013control study","volume":"15","author":"Brighina","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/sim.973","article-title":"Sample size requirements for matched case\u2013control studies of gene\u2013environment interaction","volume":"21","author":"Gauderman","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib25","unstructured":"R2011. R Development Core Team. R: a language and environment for statistical computing [online]. Available from: http:\/\/www.R-project.org [accessed 31.03.12]."},{"issue":"2528","key":"10.1016\/j.parkreldis.2013.02.008_bib26","first-page":"e1","article-title":"An exploratory analysis on gene\u2013environment interactions for Parkinson disease","volume":"33","author":"Gao","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.20438","article-title":"Multiple regions of alpha-synuclein are associated with Parkinson's disease","volume":"57","author":"Mueller","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/hmg\/ddl030","article-title":"Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease","volume":"15","author":"Mizuta","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib30","doi-asserted-by":"crossref","first-page":"e1002237","DOI":"10.1371\/journal.pgen.1002237","article-title":"Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee","volume":"7","author":"Hamza","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00702-011-0612-y","article-title":"APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population","volume":"118","author":"Kiyohara","year":"2011","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/01.wnl.0000184520.21744.a2","article-title":"Education and occupations preceding Parkinson's disease: a population-based case\u2013control study","volume":"65","author":"Frigerio","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2013.02.008_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/01.WNL.0000169023.51764.b0","article-title":"LRRK2 mutations in Parkinson's disease","volume":"65","author":"Farrer","year":"2005","journal-title":"Neurology"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:50:48Z","timestamp":1539823848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1353802013000758"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.02.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}